Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Comparing cancer vs. normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A small change makes a big difference in Hodgkin lymphoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Identification of two distinct pathways of human myelopoiesis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The splicing factor RBM25 controls MYC activity in acute myeloid leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub regulating granulo-monocytic fates

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Differences in Cell Cycle Status Underlie Transcriptional Heterogeneity in the HSC Compartment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Gene expression profiling has been used extensively to characterize cancer, identify novel subtypes and improve patient stratification. However, it has largely failed to identify transcriptional programs that differ between cancer and corresponding normal cells, and has not been efficient in identifying expression changes fundamental to disease etiology. Here we present a method that facilitates the comparison of any cancer sample to its nearest normal cellular counterpart using acute myeloid leukemia (AML) as a model. We first generated a gene expression-based landscape of the normal hematopoietic hierarchy using expression profiles from normal stem/progenitor cells and next mapped the AML patient samples to this landscape. This allowed us to identify the closest normal counterpart of individual AML samples and determine gene expression changes between cancer and normal. We find the cancer vs. normal method (CvN-method) to be superior to conventional methods in stratifying AML patients with aberrant-karyotype and in identifying common aberrant transcriptional programs with potential importance for AML etiology. Moreover, the CvN-method uncovered a novel poor-outcome subtype of normal-karyotype AML, which allowed for the generation of a highly prognostic survival signature. Collectively, our CvN-method holds great potential as a tool for the analysis of gene expression profiles of cancer patients.
OriginalsprogEngelsk
TidsskriftBlood
Vol/bind123
Udgave nummer6
Sider (fra-til)894-904
ISSN0006-4971
DOI
StatusUdgivet - 2014

ID: 42185134